Miscia M

ORCID: 0000-0002-5001-8271 · 1 paper in corpus

article 2025

How long does combined hormonal therapy suppress AMH levels in women with endometriomas? Results from an exploratory analysis of a clinical trial

European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2025.114724

BACKGROUND: Lower Anti-Müllerian hormone (AMH) levels have been observed in women with ovarian endometriomas (OMA) undergoing combined hormonal contraceptive (CHC) therapy. However, the extent and timing of AMH recovery after CHC discontinu…